- Filed
- Mar 5, 2021 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Dec 31, 2020 | 129.71M sh |
| Capex | Q3 2020 · Sep 30, 2020 | $0 |
| Capex | Q3 2020 · Sep 30, 2019 | $2.25K |
| Operating Cash Flow | Q3 2020 · Sep 30, 2020 | −$584.75K |
| Operating Cash Flow restated | Q3 2020 · Sep 30, 2019 | −$151.98K |
| Short Term Debt | Q3 2020 · Sep 30, 2020 | $374.57K |
| Short Term Debt | Q3 2020 · Dec 31, 2019 | $110K |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $30.49K |
| Cash And Equivalents | Q3 2020 · Jul 1, 2020 | $0 |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $96.41K |
| Cash And Equivalents restated | Q3 2020 · Sep 30, 2019 | $127.74K |
| Cash And Equivalents restated | Q3 2020 · Dec 31, 2018 | $18.7K |
| Stockholders Equity | Q3 2020 · Sep 30, 2020 | $1.89M |
| Stockholders Equity | Q3 2020 · Jun 30, 2020 | −$944.12K |
| Stockholders Equity | Q3 2020 · Mar 31, 2020 | −$729.86K |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | −$641.14K |
| Stockholders Equity restated | Q3 2020 · Sep 30, 2019 | −$537.9K |
| Stockholders Equity restated | Q3 2020 · Jun 30, 2019 | −$351.3K |
| Stockholders Equity restated | Q3 2020 · Mar 31, 2019 | −$258.05K |
| Stockholders Equity restated | Q3 2020 · Dec 31, 2018 | −$282.26K |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $1.12M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $483.42K |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $1.71M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $788.42K |
| Current Assets | Q3 2020 · Sep 30, 2020 | $32.05K |
| Current Assets | Q3 2020 · Dec 31, 2019 | $96.41K |
| Total Assets | Q3 2020 · Sep 30, 2020 | $3.6M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $148.28K |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $32.17K |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $94.57K |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $52.13K |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $79.2K |
| Net Income | Q3 2020 · Sep 30, 2020 | −$3.72M |
| Net Income | Q3 2020 · Sep 30, 2020 | −$4.03M |
| Net Income | Q3 2020 · Jun 30, 2020 | −$214.26K |
| Net Income | Q3 2020 · Mar 31, 2020 | −$88.77K |
| Net Income restated | Q3 2020 · Sep 30, 2019 | −$210.91K |
| Net Income restated | Q3 2020 · Sep 30, 2019 | −$429.92K |
| Net Income | Q3 2020 · Jun 30, 2019 | −$162.2K |
| Net Income restated | Q3 2020 · Mar 31, 2019 | −$56.81K |
| Operating Income | Q3 2020 · Sep 30, 2020 | $3.73M |
| Operating Income | Q3 2020 · Sep 30, 2020 | $4.04M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | $205.89K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | $420.89K |